Annovis Bio, Inc.
For the period ended Jun 12, 2024. Filed Apr 29, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 12, 2024 · Filed Apr 29, 2024
Use the contents to explore the available documents and sections.
Contents
Cover page
Show cover page
DEF 14A 1 tm243000d1_def14a.htm DEF 14A
**UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
**Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrantx
Filed by a Party other than the Registrant¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
|---|
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|---|
| x | Definitive Proxy Statement |
|---|
| ¨ | Definitive Additional Materials |
|---|
| ¨ | Soliciting Material under §240.14a-12 |
|---|
Annovis Bio, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| x | No fee required. |
|---|
| ¨ | Fee paid previously with preliminary materials. |
|---|
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |
|---|
Malvern, PA 19355
April 29, 2024
To our Stockholders:
You are cordially invited to attend our 2024 Annual Meeting of Stockholders on Wednesday, June 12, 2024, at 10:00 a.m., Eastern Daylight Time (the “Annual Meeting”) to be held as a virtual meeting at www.viewproxy.com/AnnovisBio/2024/VM.
If you attend the Annual Meeting, you will be able to vote and submit questions during the meeting by using the Virtual Control Number we have provided to you with the Notice of Internet Availability of Proxy Materials. We are pleased to furnish proxy materials to stockholders primarily over the Internet. We will commence mailing to our stockholders on or about April 29, 2024, a Notice of Internet Availability of Proxy Materials containing instructions on how to access the electronic copies of our 2024 Proxy Statement and our 2024 Annual Report on Form 10-K (the “Annual Report”) and how to vote online. Internet distribution of our proxy materials expedites receipt by stockholders, lowers the cost of the Annual Meeting, and conserves natural resources. However, if you would prefer to receive paper copies of our proxy materials, please follow the instructions included in the Notice of Internet Availability of Proxy Materials. If you choose to receive your Annual Meeting materials by mail, the notice of the Annual Meeting, Proxy Statement, the Annual Report and proxy card from our Board of Directors will be enclosed.
Please refer to the Proxy Statement for detailed information on each of the proposals and the Annual Meeting. Your vote is important, and we strongly urge all stockholders to vote their shares. For most items, including the election of directors, your shares will not be voted unless you provide voting instructions via the Internet or by returning a proxy card or voting instruction card. We encourage you to vote promptly, even if you plan to attend the Annual Meeting.
Best regards,
/s/ Maria Maccecchini
Maria Maccecchini,
President and Chief Executive Officer
Malvern, PA 19355
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held June 12, 2024
To our Stockholders:
NOTICE IS HEREBY GIVEN that you are invited to attend the 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Annovis Bio, Inc. on Wednesday, June 12, 2024, at 10:00 a.m., ET. This year’s Annual Meeting will be held virtually at www.viewproxy.com/AnnovisBio/2024/VM.
At the Annual Meeting, shareholders will vote:
| 1. | To elect the five director nominees named in the accompanying Proxy Statement; |
| 2. | To approve an amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan (the “Option Plan”); |
| 3. | To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and |
| 4. | To transact such other business as may properly be brought before the Annual Meeting or any adjournment or postponement thereof. |
Our Board of Directors unanimously recommends that you vote “FOR” the election of all of the director nominees (Proposal 1), “FOR” the proposal to approve an amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan (Proposal 2), and “FOR” the proposal to ratify Ernst & Young LLPas our independent registered public accounting firm for the fiscal year ending December 31, 2024 (Proposal 3).
The Board of Directors has fixed April 18, 2024, at the close of business, as the record date for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting.
In accordance with Securities and Exchange Commission rules, we are furnishing these proxy materials and our 2023 Annual Report on Form 10-K via the Internet. On or about April 29, 2024, we mailed to stockholders as of the record date a notice with instructions on how to access our Annual Meeting materials and how to vote via the Internet, by mail or telephone.
By Order of the Board of Directors,
/s/ Maria Maccecchini
Maria Maccecchini,
President and Chief Executive Officer
Malvern, Pennsylvania
April 29, 2024
YOUR VOTE IS IMPORTANT
If your shares are held in a brokerage account or by another nominee record holder, please be sure to mark your voting choices on the voting instruction card that accompanies this Proxy Statement. If you fail to specify your voting instructions for the election of directors or the proposal to amend the 2019 Equity Incentive Plan, your shares will not be voted in the election of directors due to rules applicable to broker voting, or we may incur additional costs to solicit votes.
TABLE OF CONTENTS
| Page | |
|---|---|
| PROXY STATEMENT | 1 |
| QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND OUR ANNUAL MEETING | 1 |
| BOARD OF DIRECTORS | 7 |
| AUDIT COMMITTEE REPORT | 15 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS, DIRECTORS AND OFFICERS | 16 |
| EXECUTIVE OFFICERS | 17 |
| EXECUTIVE AND DIRECTOR COMPENSATION | 18 |
| CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS | 22 |
| PROPOSAL 1: ELECTION OF DIRECTORS | 23 |
| PROPOSAL 2: APPROVAL OF AMENDMENT TO THE COMPANY’S 2019 EQUITY INCENTIVE PLAN | 24 |
| PROPOSAL 3: RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 30 |
| STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS FOR 2024 ANNUAL MEETING OF STOCKHOLDERS | 32 |
| DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS | 33 |
Malvern, Pennsylvania 19355
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.